Sekisui Chemical

Since its establishment in 1947, Sekisui Chemical has continuously challenged itself in new businesses and fields, evolving by providing a variety of products and services that enrich society. Today, the business environment is undergoing tremendous changes and becoming increasingly uncertain. Over the years, through superior technology and quality, we have consistently grown and will continue to maximize our management resources to develop cutting-edge areas such as "creating housing/social infrastructure" and "chemical solutions," driving innovation that contributes to the lives of people around the world and the global environment. The group will continue to work with energy and enthusiasm, courageously taking on challenges to meet stakeholders' expectations. We are committed to expanding our business globally and achieving sustainable growth. By leveraging advanced technologies, the company creates high-quality products that contribute to fulfilling and healthy living, developing various analyzers and in vitro diagnostic devices with a focus on coagulants, lifestyle diseases, and infectious disease sectors. Primarily utilizing optical active compounds obtained through synthetic amino acids, we produce active pharmaceutical ingredients (APIs), intermediates, and pharmaceutical-grade amino acids, providing contract manufacturing services to pharmaceutical companies. With our advanced technical capabilities, we support comprehensive drug development for pharmaceutical companies and academia, from the exploratory stage to post-marketing. We offer several types of research and provide various raw materials to diagnostic and pharmaceutical companies worldwide, ranging from diagnostic raw materials to enzymes controlling antibiotic processes and enzymes used in biopharmaceuticals. Building on these technologies and experiences, we have launched our CDMO business.